U.S. Machinery Stock News

NYSE:KNF
NYSE:KNFBasic Materials

Assessing Knife River (KNF) Valuation After Wells Fargo Downgrade And Higher Price Target

Wells Fargo downgrade puts Knife River in focus Wells Fargo’s decision to downgrade Knife River (KNF) to Equal-Weight while lifting its price target to $81 has put fresh attention on the stock and how analysts currently view its prospects. See our latest analysis for Knife River. Knife River’s recent momentum has been firm, with a 23.6% 90 day share price return and year to date share price return of 10.31% taking the stock to $80.24, even though the 1 year total shareholder return is a...
NYSE:IIIN
NYSE:IIINBuilding

Insteel Industries (IIIN) Net Margin Rebound Challenges Bearish Earnings Narratives

Insteel Industries (IIIN) opened its new fiscal year with Q1 2026 revenue of US$159.9 million and basic EPS of US$0.39, alongside net income of US$7.6 million. The company has seen revenue move from US$129.7 million and EPS of US$0.06 in Q1 2025 to a trailing twelve month revenue base of US$677.9 million and EPS of US$2.44. This gives investors a clearer sense of the earnings power behind the latest quarter and the improvement in net margin from 3.6% to 7% over the past year. See our full...
NYSE:J
NYSE:JProfessional Services

Is Jacobs Solutions (J) Fairly Priced After Recent Steady Multi Year Share Gains

Wondering if Jacobs Solutions at around US$141.50 is giving you fair value for the risk you take, or if the price is leaving too much on the table. The stock has seen returns of 2.2% over the last 7 days, 5.6% over 30 days, 4.5% year to date, 4.3% over 1 year, 48.1% over 3 years and 60.4% over 5 years, which naturally raises questions about how much of that performance is already reflected in the current share price. Recent news around Jacobs Solutions has focused on its role as a large US...
NasdaqGS:GLNG
NasdaqGS:GLNGOil and Gas

The Bull Case For Golar LNG (GLNG) Could Change Following Long-Term Argentina FLNG Charter Progress - Learn Why

In the past few months, Goldman Sachs began covering Golar LNG Limited with a positive view, while Golar confirmed that all Conditions Precedent for its 20‑year MKII FLNG charter with Southern Energy in Argentina had been satisfied, securing a long-term commercial arrangement. These developments, occurring against the backdrop of Argentina’s recent election of Javier Milei, meaningfully reduce policy uncertainty around the project and sharpen focus on Golar’s exposure to LNG-linked commodity...
NasdaqGS:BBSI
NasdaqGS:BBSIProfessional Services

Assessing Barrett Business Services (BBSI) Valuation After New Employee File Cabinet HR Tech Launch

What the new Employee File Cabinet launch means for BBSI shareholders Barrett Business Services (BBSI) has rolled out its Employee File Cabinet HRIS module within the BBSI Client Portal, built with Box, giving clients a secure, centralized hub for key HR documents. The launch highlights BBSI’s ongoing push to consolidate HR workflows into a single portal experience. The company points to potential benefits around compliance, time savings, and employee access to their own documents. See our...
NYSE:NRGV
NYSE:NRGVElectrical

Why Energy Vault (NRGV) Is Up 11.5% After Launching Its First ERCOT Asset Vault Project

Energy Vault Holdings, Inc. previously filed a shelf registration for US$180.55 million of common stock, while also beginning construction on the 150 MW/300 MWh SOSA Energy Center battery storage project in Madison County, Texas under its Asset Vault "Own & Operate" platform. This combination of fresh financing capacity and the company’s first Asset Vault project in the ERCOT North market highlights a shift toward owned infrastructure backed by recurring revenues and supported by a US$300...
NasdaqGS:CVGW
NasdaqGS:CVGWFood

Calavo Growers (CVGW) Margin Turnaround Challenges Cautious Earnings Narratives

Calavo Growers (CVGW) just wrapped up FY 2025 with Q4 revenue of US$124.7 million and basic EPS of US$0.21. Trailing 12 month revenue came in at US$648.4 million and EPS at US$1.11, supported by a trailing net profit margin of 3.1% versus 1.0% in the prior year. Over the last few quarters, revenue has ranged from US$154.4 million to US$190.5 million with quarterly EPS between US$0.21 and US$0.38. This points to a picture of improving profitability that puts margins, rather than top line...
NYSE:MS
NYSE:MSCapital Markets

Morgan Stanley (MS) Earnings Surge And Margin Strength Challenge Cautious Growth Narratives

Morgan Stanley (MS) has wrapped up FY 2025 with fourth quarter revenue of US$17.9b and basic EPS of US$2.72, capping a twelve month run that produced total revenue of US$70.3b and basic EPS of US$10.32, alongside a 26.9% rise in earnings and a net profit margin of 23.1% compared with 20.8% the year before. Over the past six quarters, the bank has seen quarterly revenue move from US$15.3b in Q3 2024 to US$17.9b in Q4 2025, while quarterly basic EPS moved from US$1.91 to US$2.72. This set up a...
NasdaqGM:AXSM
NasdaqGM:AXSMPharmaceuticals

Assessing Axsome Therapeutics (AXSM) After An 86% One-Year Share Price Surge

Wondering if Axsome Therapeutics at around US$174 a share still offers value, or if most of the opportunity has already been priced in? This article is built to help you frame that question clearly. The stock has seen a 3.9% return over the past week and 18.6% over the last 30 days, while year to date it is at a 2.5% decline and up 85.9% over the last year and 155.9% over three years, with a 129.4% return over five years. Recent coverage of Axsome has focused on its position in...
NYSE:DEI
NYSE:DEIOffice REITs

Is Douglas Emmett (DEI) Now Attractive After Prolonged Share Price Weakness And Office Market Concerns

If you are wondering whether Douglas Emmett is priced attractively today, or if the share price still does not reflect its underlying real estate assets, this article explains what the current market value might be telling you. The stock recently closed at US$10.97, with returns of a 1.6% decline over 7 days, a 4.8% decline over 30 days, a 0.9% decline year to date, a 32.8% decline over 1 year and a 51.5% decline over 5 years. This performance may have changed how investors view its risk and...
NasdaqCM:SLS
NasdaqCM:SLSBiotechs

A Look At SELLAS Life Sciences Group (SLS) Valuation After New IMPACT AML Clinical Collaboration

SELLAS Life Sciences Group (SLS) is back on investor radars after it agreed with the IMPACT AML network to run a European clinical study of its CDK9 inhibitor, SLS009, in high risk newly diagnosed AML. See our latest analysis for SELLAS Life Sciences Group. The new IMPACT AML agreement comes after a volatile spell where traders focused on financing risk, yet the stock still shows a 74.55% 30 day share price return and a very large 1 year total shareholder return. This suggests momentum has...
NYSE:GENI
NYSE:GENIHospitality

Should Wall Street’s Praise of GENI’s Media Strategy Refocus the Genius Sports (GENI) Investment Debate?

In recent days, multiple research firms including Benchmark, Wells Fargo, and Truist Financial have issued upbeat coverage on Genius Sports, emphasizing its operating leverage, media monetization approach, and long-term revenue and cash flow ambitions. This wave of positive attention underscores how Genius Sports’ data partnerships and advertising-focused media strategy have become central to its long-term business case. Building on this new analyst optimism around Genius Sports’ media...
NYSE:GS
NYSE:GSCapital Markets

Goldman Sachs Group (GS) Earnings Rebound And 27.4% Margin Test Moderate Growth Narratives

Goldman Sachs FY 2025 Earnings Snapshot Goldman Sachs (GS) closed out FY 2025 with fourth quarter revenue of US$15.6 billion and basic EPS of US$14.27 on net income of US$4.4 billion, setting the tone for how investors are reading the latest numbers. Over the past six reported quarters, the bank has seen quarterly revenue move from US$12.3 billion in Q3 2024 to US$13.5 billion in Q4 2024 and then to US$15.6 billion in Q4 2025, while basic EPS shifted from US$8.52 to US$12.14 to US$14.27 over...
NasdaqCM:MREO
NasdaqCM:MREOBiotechs

Why Mereo BioPharma (MREO) Is Up 69.9% After Mixed Setrusumab Phase 3 Results And Pipeline Shift

Mereo BioPharma Group recently reported that its Phase 3 Orbit and Cosmic trials of setrusumab in osteogenesis imperfecta missed their primary fracture reduction endpoints but achieved strong statistical improvements in bone mineral density, while also updating investors that its approximately US$41,000,000 cash balance at 31 December 2025 is expected to fund operations to mid-2027. Alongside reassessing the future of setrusumab with partner Ultragenyx, Mereo is pushing ahead with a single...
NYSE:ALV
NYSE:ALVAuto Components

Is Autoliv (ALV) Attractive After Strong Multi Year Share Price Performance

If you are wondering whether Autoliv’s current share price lines up with its underlying value, this breakdown is designed to walk you through the key numbers that matter. Autoliv shares last closed at US$128.45, with returns of 4.2% over 7 days, 5.9% over 30 days, 5.2% year to date, 36.0% over 1 year and 71.8% over 3 years. This naturally raises questions about how much of this performance is already reflected in the price. Recent attention on Autoliv has centered on its position in vehicle...
NasdaqGS:ROOT
NasdaqGS:ROOTInsurance

Did Cash Strain and a New Kikoff Partnership Just Shift Root's (ROOT) Investment Narrative?

In the past week, digital auto insurer Root faced renewed scrutiny after a Wells Fargo analyst highlighted weakening operating cash flow, reduced available capital, and an underwriting loss reflected in a 102% combined ratio. At the same time, Root Insurance and personal finance platform Kikoff announced an embedded insurance partnership, integrating Root’s data-driven auto policy quoting and purchasing directly into the Kikoff app to broaden access to mobile-first coverage. We’ll now...
NasdaqCM:PCT
NasdaqCM:PCTChemicals

Is PureCycle (PCT) Turning High-Profile Sports Branding Into a Credible Capacity-Build Strategy?

PureCycle Technologies recently announced a collaboration with Churchill Container and 4ocean to supply Run It Back souvenir cups made with its PureFive recycled resin at the College Football Playoff National Championship, while also revising its construction agreement for a future recycling facility in Augusta, Georgia, including a US$500,000 payment to AEDA and updated project milestones. Together, the high-visibility sustainability initiative at a major sporting event and the recalibrated...
NasdaqCM:KOPN
NasdaqCM:KOPNSemiconductor

Can Kopin’s (KOPN) First DarkWAVE Order Redefine Its Defense Microdisplay Positioning?

Kopin Corporation recently announced that Theon International placed a US$1.0 million development order for its 960p DarkWAVE™ module, moving the AR‑ and thermal‑enabled clip‑on night-vision platform from prototype to production readiness for international defense customers in 2026. This first meaningful DarkWAVE order targets the large aftermarket of an estimated more than 2 million fielded night-vision goggles worldwide, potentially turning existing systems into AR-enabled devices without...
NYSE:EHAB
NYSE:EHABHealthcare

Do Enhabit (EHAB) Analyst Upgrades Hint At A Stronger Reimbursement And Growth Narrative?

Recently, TD Cowen and UBS both upgraded Enhabit to Buy, signaling a shift in analyst opinion on the home health and hospice provider. This cluster of upgrades suggests large institutions are reassessing Enhabit’s risk‑reward profile in light of its evolving operating backdrop. Next, we’ll examine how this renewed analyst confidence might influence Enhabit’s investment narrative, particularly around reimbursement resilience and growth. AI is about to change healthcare. These 30 stocks are...
NYSE:REVG
NYSE:REVGMachinery

Three Stocks That May Be Priced Below Their Estimated Value In January 2026

As the United States stock market experiences a resurgence, with major indices like the Nasdaq, Dow Jones Industrial Average, and S&P 500 climbing on strong tech earnings and easing geopolitical tensions, investors are increasingly focused on identifying opportunities that may be undervalued. In this environment of fluctuating oil prices and robust tech performance, discerning stocks that are priced below their estimated value can offer potential advantages for those looking to capitalize on...
NasdaqCM:BWB
NasdaqCM:BWBBanks

Top Growth Companies Insiders Are Backing In January 2026

As the U.S. stock market experiences a surge, driven by strong performances in the tech sector and easing geopolitical tensions, investors are keenly observing growth companies that insiders are backing with significant ownership stakes. In this environment of rising indices and fluctuating oil prices, stocks with high insider ownership can offer an added layer of confidence for investors seeking to align with those who have intimate knowledge of their company's potential.
NasdaqCM:VFF
NasdaqCM:VFFFood

Undervalued Opportunities: Penny Stocks To Watch In January 2026

As the U.S. stock market experiences a surge, led by tech rallies and tempered oil prices, investors are keenly observing opportunities across various sectors. Penny stocks, while often considered niche due to their lower price points and smaller market capitalizations, continue to attract attention for their potential growth prospects. These stocks can offer a compelling mix of affordability and growth potential when backed by strong financials; let's explore several that might stand out in...